Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP)

P. Cabral, M. Gnoni, T. Wiemken, R. Karanjeet, L. Goss, P. Nolting, S. Marnini, P. Peyrani, J. Ramirez (Louisville, United States Of America)

Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Cabral, M. Gnoni, T. Wiemken, R. Karanjeet, L. Goss, P. Nolting, S. Marnini, P. Peyrani, J. Ramirez (Louisville, United States Of America). Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP). Eur Respir J 2009; 34: Suppl. 53, 2392

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment failure of severe and ventilator-associated pneumonia
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012

Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005

Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011


Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Late-onset ventilator-associated pneumonia in patients with acute nervous system infections
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006

How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Acute lung injury and ventilator-associated pneumonia: introduction
Source: Eur Respir J 2003; 22: 1S
Year: 2003


Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Preventing ventilator-associated pneumonia
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017


Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes?
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


"Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP))
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013



Cryptogenic organizing pneumonia (COP) as a cause of severe acute respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 507s
Year: 2004